CD274 and hepatocellular carcinoma: In addition, PD-L1 and PD-1 might be used as two biomarkers to guide CIK treatment in HCC because high PD-L1 expression and a high infiltration of PD-1 + lymphocytes in HCC were all found to be correlated with good efficacy for CIK therapy [204, 205].